Online first
Original Article
Published online: 2023-06-14
Predictive value of systemic inflammatory response index (SIRI) for complex coronary artery disease occurrence in patients presenting with angina equivalent symptoms
1
, 2, 3, 1, 4, 3, 1
, 2, 3, 1, 4, 3, 1
Pubmed: 37314004
Abstract
Background: Currently, atherosclerotic cardiovascular disease is the major cause of mortality world-wide. Inflammatory processes are postulated to be a major driving force for coronary plaque initiation and progression and can be evaluated by simple inflammatory markers from whole blood count analysis. Among hematological indexes, systemic inflammatory response index (SIRI) is defined as a quotient of neutrophils and monocytes, divided by lymphocyte count. The aim of the present retrospective analysis was to present the predictive role of SIRI for coronary artery disease (CAD) occurrence.
Methods: There were 256 patients (174 [68%] men and 82 [32%] women) in the median (Q1–Q3) age of 67 (58–72) years enrolled into retrospective analysis due to angina pectoris equivalent symptoms. A model for predicting CAD was created based on demographic data and blood cell parameters reflecting an inflammatory response.
Results: In patients with single/complex coronary disease the logistic regression multivariable analysis revealed predictive value of male gender (odds ratio [OR]: 3.98, 95% confidence interval [CI]: 1.38–11.42, p = 0.010), age (OR: 5.57, 95% CI: 0.83–0.98, p = 0.001), body mass index (OR: 0.89, 95% CI: 0.81–0.98, p = 0.012), and smoking (OR: 3.66, 95% CI: 1.71–18.22, p = 0.004). Among laboratory parameters, SIRI (OR: 5.52, 95% CI: 1.89–16.15, p = 0.029) and red blood cell distribution width (OR: 3.66, 95% CI: 1.67–8.04, p = 0.001) were found significant.
Conclusions: Systemic inflammatory response index, a simple hematological index, may be helpful in patients with angina equivalent symptoms to diagnose CAD. Patients presenting with SIRI above 1.22 (area under the curve: 0.725, p < 0.001) have a higher probability of single and complex coronary disease.
Keywords: coronary artery diseasesystemic inflammatory response index (SIRI)angiography
References
- Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009; 53(3): 317–333.
- Arnold N, Lechner K, Waldeyer C, et al. Inflammation and cardiovascular disease: the future. Eur Cardiol. 2021; 16: e20–e28.
- Rusnak J, Fastner C, Behnes M, et al. Biomarkers in stable coronary artery disease. Curr Pharm Biotechnol. 2017; 18(6): 456–471.
- Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020; 383(19): 1838–1847.
- Liu GQ, Zhang WJ, Shangguan JH, et al. Association of derived neutrophil-to-lymphocyte ratio with prognosis of coronary heart disease after PCI. Front Cardiovasc Med. 2021; 8: 705862.
- Arnold KA, Blair JE, Paul JD, et al. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease. Exp Physiol. 2019; 104(9): 1343–1352.
- Sbrana S, Campolo J, Clemente A, et al. Blood monocyte phenotype fingerprint of stable coronary artery disease: a cross-sectional substudy of smartool clinical trial. Biomed Res Int. 2020; 2020: 8748934.
- Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022; 54(1): 1667–1677.
- Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Neutrophil counts, neutrophil-to-lymphocyte ratio, and systemic inflammatory response index (SIRI) predict mortality after off-pump coronary artery bypass surgery. Cells. 2022; 11(7).
- Kuwahara Go, Tashiro T. Current status of off-pump coronary artery bypass. Ann Thorac Cardiovasc Surg. 2020; 26(3): 125–132.
- Al-Ruzzeh S, Ambler G, Asimakopoulos G, et al. United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome. Off-Pump coronary artery bypass (OPCAB) surgery reduces risk-stratified morbidity and mortality: a united kingdom multi-center comparative analysis of early clinical outcome. Circulation. 2003; 108(Suppl 1): II1–II8.
- Katritsis DG, Mark DB, Gersh BJ. Revascularization in stable coronary disease: evidence and uncertainties. Nat Rev Cardiol. 2018; 15(7): 408–419.
- Mehta SR. Achieving complete revascularization for multivessel coronary artery disease. Circulation. 2021; 144(2): 110–112.
- Fukunaga M, Fujii K, Mintz GS, et al. Distribution of pressure gradients along the left anterior descending artery in patients with angiographically normal arteries. Catheter Cardiovasc Interv. 2020; 96(1): E67–E74.
- Levitt K, Guo H, Wijeysundera HC, et al. Predictors of normal coronary arteries at coronary angiography. Am Heart J. 2013; 166(4): 694–700.
- Dryer K, Gajjar M, Narang N, et al. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018; 314(5): H1033–H1042.
- Xia Y, Xia C, Wu L, et al. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. J Clin Med. 2023; 12(3).
- Yaşar E, Bayramoğlu A. Systemic immune-inflammation index as a predictor of microvascular dysfunction in patients with cardiac syndrome X. Angiology. 2022; 73(7): 615–621.
- Candemir M, Kiziltunç E, Nurkoç S, et al. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021; 72(6): 575–581.
- Cannon RO. Chest pain with normal coronary angiograms: is the heart innocent or guilty? J Am Coll Cardiol. 1990; 16(3): 596–598.
- Knuuti J, Wijns W, Saraste A. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41: 407–477.
- Sheikh M, Ben-Nakhi A, Shukkur AM, et al. Accuracy of 64-multidetector-row computed tomography in the diagnosis of coronary artery disease. Med Princ Pract. 2009; 18(4): 323–328.
- Alani A, Nakanishi R, Budoff MJ. Recent improvement in coronary computed tomography angiography diagnostic accuracy. Clin Cardiol. 2014; 37(7): 428–433.
- Stefanini GG, Windecker S. Can coronary computed tomography angiography replace invasive angiography? Coronary computed tomography angiography cannot replace invasive angiography. Circulation. 2015; 131(4): 418–426.
- Gotschy A, Niemann M, Kozerke S, et al. Cardiovascular magnetic resonance for the assessment of coronary artery disease. Int J Cardiol. 2015; 193: 84–92.
- Huang Y, Hui Q, Gwinn M, et al. Sexual differences in genetic predisposition of coronary artery disease. Circ Genom Precis Med. 2021; 14(1): e003147–e003158.
- Kyker KA, Limacher MC. Gender differences in the presentation and symptoms of coronary artery disease. Curr Womens Health Rep. 2002; 2(2): 115–119.
- Urbanowicz T, Michalak M, Olasińska-Wiśniewska A, et al. Gender differences in coronary artery diameters and survival results after off-pump coronary artery bypass (OPCAB) procedures. J Thorac Dis. 2021; 13(5): 2867–2873.
- Bauersachs R, Zeymer U, Brière JB, et al. Burden of coronary artery disease and peripheral artery disease: a literature review. Cardiovasc Ther. 2019; 2019: 8295054.
- Hosseini K, Mortazavi SH, Sadeghian S, et al. Prevalence and trends of coronary artery disease risk factors and their effect on age of diagnosis in patients with established coronary artery disease: Tehran Heart Center (2005-2015). BMC Cardiovasc Disord. 2021; 21(1): 477–488.
- Sniderman AD, Holme I, Aastveit A, et al. Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. Am J Cardiol. 2007; 100(2): 217–221.
- Lanjanian H, Najd Hassan Bonab L, Akbarzadeh M, et al. Sex, age, and ethnic dependency of lipoprotein variants as the risk factors of ischemic heart disease: a detailed study on the different age-classes and genders in Tehran Cardiometabolic Genetic Study (TCGS). Biol Sex Differ. 2022; 13(1): 4–14.
- Mandviwala T, Khalid U, Deswal A. Obesity and cardiovascular disease: a risk factor or a risk marker? Curr Atheroscler Rep. 2016; 18(5): 21–31.
- Katta N, Loethen T, Lavie CJ, et al. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging. Curr Probl Cardiol. 2021; 46(3): 100655–100678.
- Iwańczyk S, Smukowska-Gorynia A, Woźniak P, et al. Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome. Pol Arch Intern Med. 2022; 132(7-8).
- Kalyoncuoglu M, Biter Hİ, Ozturk S, et al. Predictive accuracy of lymphocyte-to-monocyte ratio and monocyte-to-high-density-lipoprotein-cholesterol ratio in determining the slow flow/no-reflow phenomenon in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020; 31(6): 518–526.
- Maron DJ, Hochman JS, O'Brien SM, et al. ISCHEMIA Trial Research Group. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J. 2018; 201: 124–135.
- Urbanowicz T, Olasińska-Wiśniewska A, Michalak M, et al. Pre-operative systemic inflammatory response index influences long-term survival rate in off-pump surgical revascularization. PLoS One. 2022; 17(12): e0276138.
- Yoshioka K, Tanaka R, Takagi H, et al. Diagnostic accuracy of a modified subtraction coronary CT angiography method with short breath-holding time: a feasibility study. Br J Radiol. 2016; 89(1066): 20160489.
- Ilia R, Carmel S, Carlos C, et al. Relation between shortness of breath, left ventricular end diastolic pressure and severity of coronary artery disease. Int J Cardiol. 1995; 52(2): 153–155.
- Budoff MJ, Mayrhofer T, Ferencik M, et al. Prognostic Value of Coronary Artery Calcium in the PROMISE Study (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation. 2017; 136(21): 1993–2005.
